From FDA Clinical studies
Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 h post infection with SARS-CoV-2 able to effect ~5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans.
So a balanced conversation .I don't care either way but some people swallow anything ,like you dd.
- Forums
- ASX - By Stock
- seizing the mkt opportunity/ current mkt conditions in the usa is a good example
From FDA Clinical studiesAlthough several clinical trials are...
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.84M |
Open | High | Low | Value | Volume |
2.2¢ | 2.2¢ | 2.0¢ | $82.21K | 3.829M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1315249 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 250000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1315249 | 0.020 |
5 | 714281 | 0.019 |
12 | 1100053 | 0.018 |
7 | 1152891 | 0.017 |
6 | 1868529 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 250000 | 1 |
0.023 | 305087 | 2 |
0.024 | 154809 | 3 |
0.025 | 486936 | 6 |
0.026 | 45454 | 1 |
Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online